Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1999
08/18/1999EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY
08/18/1999EP0935612A1 Precursors of catalytic antibodies
08/18/1999EP0935611A1 Serine protease inhibitors
08/18/1999EP0935610A1 Novel human interferon-inducible protein
08/18/1999EP0935608A1 Cytotoxic peptides
08/18/1999EP0935601A2 Arylamino fused pyridines and pyrimidines
08/18/1999EP0935471A1 Mononuclear phagocytes in therapeutic drug delivery
08/18/1999EP0935467A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof
08/18/1999EP0935465A1 Novel substituted imidazole compounds
08/18/1999EP0796257B1 Malonic acid based matrix metalloproteinase inhibitors
08/18/1999EP0779808B1 Triphenylethylenes for the prevention and treatment of osteoporosis
08/18/1999EP0697869B1 Transdermal therapeutic systems for the administration of serotonin agonists
08/18/1999EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
08/18/1999EP0620817B1 Piperazine derivatives as 5-ht receptors antagonists
08/18/1999CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium
08/18/1999CN1226246A Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/18/1999CN1225824A Diagnosis and treatment and health-care medicinal liquor of external use for the five sense organs
08/18/1999CN1225819A Devitalization method for bone-matrix gelatin carrier
08/17/1999US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents
08/17/1999US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof
08/17/1999US5939550 Preparing acid-addition salt of prodrug acid of naphthyridinone antibiotic by treating ester of compound with protic acid, condensing intermediate with dipeptide, subjecting n-protected prodrug ester to acid hydrolysis
08/17/1999US5939525 Methods of treating inflammation and compositions therefor
08/17/1999US5939462 NPY5 receptor antagonists and methods for using same
08/17/1999US5939452 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists
08/17/1999US5939449 Novel compounds having high affinity for the neurotensin receptors
08/17/1999US5939443 Selective β3 adrenergic agonists
08/17/1999US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists
08/17/1999US5939433 Quinuclidine derivatives
08/17/1999US5939422 An enzyme inhibitor as bronchodilator, relaxants, antiinflammatory agent for treating asthma, allergies, inflammation, depression, dementia, diseases associated with abnormal high level of cytokine
08/17/1999US5939416 Inhibit ras function, use for treating tumor cells expressing an activated ras oncogene in mammals
08/17/1999US5939415 A!-annellated pyrrole derivatives and their use in pharmacology
08/17/1999US5939413 Tachykinin mediated diseases in humans for respiratory system disorders like asthma, bronchitis, rhinitis or eye diseases or skin disorders
08/17/1999US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies
08/17/1999US5939407 Vitamin d receptors for nervous system disorders
08/17/1999US5939405 Potassium channel modulators
08/17/1999US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents
08/17/1999US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/17/1999US5939386 Growth hormone (gh) or somatotropin, secreted by the pituitary gland constitute a family of hormones
08/17/1999US5939321 Mammalian tolloid-like gene and protein
08/17/1999US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds
08/17/1999US5939095 At least one parasympathomimetically active substance and at least one parasympatholytically active substance
08/17/1999CA2179008C 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
08/17/1999CA2136824C Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism
08/17/1999CA2002483C Fluoxetine analog
08/12/1999WO1999040196A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
08/12/1999WO1999040192A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14
08/12/1999WO1999040187A1 Nucleic acids provided for modulating cellular activation
08/12/1999WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999WO1999040117A1 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF
08/12/1999WO1999040110A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
08/12/1999WO1999040108A1 New compound
08/12/1999WO1999040104A1 Neokine protein and nucleic acid molecules and uses therefor
08/12/1999WO1999040099A1 5'-deoxycytidine derivatives
08/12/1999WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999040088A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999WO1999040083A2 Bifunctional tryptase inhibitors
08/12/1999WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999WO1999040073A2 Tryptase inhibitors
08/12/1999WO1999040069A1 Benzyloxy prodigiosine compounds
08/12/1999WO1999040068A2 2-aminoquinoline derivatives having d4-agonistic activity
08/12/1999WO1999040067A2 Benzisoxazole derivatives having d4-antagonistic activity
08/12/1999WO1999040064A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/12/1999WO1999040061A2 Novel dihydroxyhexanoic acid derivatives
08/12/1999WO1999040056A1 Hydroxylation activated prodrugs
08/12/1999WO1999039734A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
08/12/1999WO1999039731A1 Copolymer compositions for oral delivery
08/12/1999WO1999039729A2 Use of heregulin as an epithelial cell growth factor
08/12/1999WO1999039727A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999WO1999039726A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999WO1999039720A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
08/12/1999WO1999039718A1 Medicine for treating apoptosis dysfunction containing oligosaccharides
08/12/1999WO1999039714A1 Remedies for neurological disorders
08/12/1999WO1999039710A1 Use of 2-amino-6- trifluoromehthoxy- benzothiazole for preventing or treating cerebellum dysfunction
08/12/1999WO1999039706A1 Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl) ethylenediamine-n, n'-diacetic acid for iron chelating therapy
08/12/1999WO1999039702A2 Method for regulating size and growth of vascularized normal tissue
08/12/1999WO1999039647A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
08/12/1999WO1999029339A3 Prevention and/or treatment of allergic conditions
08/12/1999WO1999028343A3 Hydrophobically-modified protein compositions and methods
08/12/1999WO1999028304A3 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
08/12/1999WO1999027919A3 Cyp2a enzymes and their use in therapeutic and diagnostic methods
08/12/1999WO1999024063A9 Compositions providing for increased igf-i solubility
08/12/1999WO1999021875A9 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
08/12/1999WO1999021574A9 Enhancement of morphogen activity
08/12/1999WO1999002143A3 Medicament comprising adenosine
08/12/1999WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
08/12/1999WO1998058633A3 Microdose therapy of vascular conditions by no donors
08/12/1999WO1998049146A3 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
08/12/1999WO1998048784A3 Method and composition for modulating amyloidosis
08/12/1999WO1998008505A8 Pharmaceutical compounds
08/12/1999DE19801265C1 Inhibierung von CD95-unabhängiger Apoptose bei AIDS Inhibiting CD95-independent apoptosis in AIDS
08/12/1999CA2327545A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
08/12/1999CA2321257A1 Remedies for neurological disorders
08/12/1999CA2321025A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999CA2320416A1 New compound
08/12/1999CA2320300A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
08/12/1999CA2320144A1 Neokine protein and nucleic acid molecules and uses therefor
08/12/1999CA2319764A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999CA2319677A1 Medicine for treating apoptosis dysfunction containing oligosaccharides